The history of Viagra, and its creator copyright, presents a intriguing case study for investors. Originally a blockbuster drug, generating billions in income, its exclusivity period created a wave of knock-off medications, significantly eroding its position . While specific firms may seek to capitalize on related treatments , the current landscape